{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:00:18Z","timestamp":1769616018178,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejim.2024.01.017","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T01:48:43Z","timestamp":1705801723000},"page":"135-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis"],"prefix":"10.1016","volume":"122","author":[{"given":"Alessandro","family":"Lagan\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Fucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Genoese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.01.017_bib0001","doi-asserted-by":"crossref","first-page":"275e84","DOI":"10.1016\/j.beha.2012.07.005","article-title":"Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs","volume":"25","author":"Decousus","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"issue":"03","key":"10.1016\/j.ejim.2024.01.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004982.pub4","article-title":"Treatment for superficial thrombophlebitis of the leg","volume":"3","author":"Di Nisio","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2Suppl","key":"10.1016\/j.ejim.2024.01.017_bib0003","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.ejim.2024.01.017_bib0004","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa0912072","article-title":"Fondaparinux for the treatment of superficial-vein thrombosis in the legs","volume":"363","author":"Decousus","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.017_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0039-1677793","article-title":"Treatment of superficial vein thrombosis: a systematic review and meta-analysis","volume":"119","author":"Duffett","year":"2019","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.017_bib0006","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1060028020970618","article-title":"Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension-a systematic review","volume":"55","author":"Brokmeier","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.017_bib0007","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0040-1718891","article-title":"Rivaroxaban compared to placebo for the treatment of leg superficial vein thrombosis: a randomized trial","volume":"46","author":"Kearon","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.017_bib0008","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.017_bib0009","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/bjh.17757","article-title":"Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital","volume":"196","author":"Clapham","year":"2022","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.017_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejvs.2021.04.015","article-title":"Management and outcomes of patients with isolated superficial vein thrombosis under real life conditions (INSIGHTS-SVT)","volume":"62","author":"Bauersachs","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:39:59Z","timestamp":1760607599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":10,"alternative-id":["S0953620524000268"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}